Causes of fever in returning travelers: a European multicenter prospective cohort study.


Journal

Journal of travel medicine
ISSN: 1708-8305
Titre abrégé: J Travel Med
Pays: England
ID NLM: 9434456

Informations de publication

Date de publication:
21 Mar 2022
Historique:
received: 02 12 2021
revised: 04 01 2022
accepted: 06 01 2022
pubmed: 19 1 2022
medline: 19 4 2022
entrez: 18 1 2022
Statut: ppublish

Résumé

Etiological diagnosis of febrile illnesses in returning travelers is a great challenge, particularly when presenting with no focal symptoms [acute undifferentiated febrile illnesses (AUFI)], but is crucial to guide clinical decisions and public health policies. In this study, we describe the frequencies and predictors of the main causes of fever in travelers. Prospective European multicenter cohort study of febrile international travelers (November 2017-November 2019). A predefined diagnostic algorithm was used ensuring a systematic evaluation of all participants. After ruling out malaria, PCRs and serologies for dengue, chikungunya and Zika viruses were performed in all patients presenting with AUFI ≤ 14 days after return. Clinical suspicion guided further microbiological investigations. Among 765 enrolled participants, 310/765 (40.5%) had a clear source of infection (mainly traveler's diarrhea or respiratory infections), and 455/765 (59.5%) were categorized as AUFI. AUFI presented longer duration of fever (p < 0.001), higher hospitalization (p < 0.001) and ICU admission rates (p < 0.001). Among travelers with AUFI, 132/455 (29.0%) had viral infections, including 108 arboviruses, 96/455 (21.1%) malaria and 82/455 (18.0%) bacterial infections. The majority of arboviral cases (80/108, 74.1%) was diagnosed between May and November. Dengue was the most frequent arbovirosis (92/108, 85.2%). After 1 month of follow-up, 136/455 (29.9%) patients with AUFI remained undiagnosed using standard diagnostic methods. No relevant differences in laboratory presentation were observed between undiagnosed and bacterial AUFI. Over 40% of returning travelers with AUFI were diagnosed with malaria or dengue, infections that can be easily diagnosed by rapid diagnostic tests. Arboviruses were the most common cause of AUFI (above malaria) and most cases were diagnosed during Aedes spp. high season. This is particularly relevant for those areas at risk of introduction of these pathogens. Empirical antibiotic regimens including doxycycline or azithromycin should be considered in patients with AUFI, after ruling out malaria and arboviruses.

Sections du résumé

BACKGROUND BACKGROUND
Etiological diagnosis of febrile illnesses in returning travelers is a great challenge, particularly when presenting with no focal symptoms [acute undifferentiated febrile illnesses (AUFI)], but is crucial to guide clinical decisions and public health policies. In this study, we describe the frequencies and predictors of the main causes of fever in travelers.
METHODS METHODS
Prospective European multicenter cohort study of febrile international travelers (November 2017-November 2019). A predefined diagnostic algorithm was used ensuring a systematic evaluation of all participants. After ruling out malaria, PCRs and serologies for dengue, chikungunya and Zika viruses were performed in all patients presenting with AUFI ≤ 14 days after return. Clinical suspicion guided further microbiological investigations.
RESULTS RESULTS
Among 765 enrolled participants, 310/765 (40.5%) had a clear source of infection (mainly traveler's diarrhea or respiratory infections), and 455/765 (59.5%) were categorized as AUFI. AUFI presented longer duration of fever (p < 0.001), higher hospitalization (p < 0.001) and ICU admission rates (p < 0.001). Among travelers with AUFI, 132/455 (29.0%) had viral infections, including 108 arboviruses, 96/455 (21.1%) malaria and 82/455 (18.0%) bacterial infections. The majority of arboviral cases (80/108, 74.1%) was diagnosed between May and November. Dengue was the most frequent arbovirosis (92/108, 85.2%). After 1 month of follow-up, 136/455 (29.9%) patients with AUFI remained undiagnosed using standard diagnostic methods. No relevant differences in laboratory presentation were observed between undiagnosed and bacterial AUFI.
CONCLUSIONS CONCLUSIONS
Over 40% of returning travelers with AUFI were diagnosed with malaria or dengue, infections that can be easily diagnosed by rapid diagnostic tests. Arboviruses were the most common cause of AUFI (above malaria) and most cases were diagnosed during Aedes spp. high season. This is particularly relevant for those areas at risk of introduction of these pathogens. Empirical antibiotic regimens including doxycycline or azithromycin should be considered in patients with AUFI, after ruling out malaria and arboviruses.

Identifiants

pubmed: 35040473
pii: 6510556
doi: 10.1093/jtm/taac002
pii:
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of International Society of Travel Medicine. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Daniel Camprubí-Ferrer (D)

ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.

Ludovico Cobuccio (L)

Swiss Tropical and Public Health Institute, Basel, Switzerland.
Center for Primary Care and Public Health, University of Lausanne, Switzerland.

Steven Van Den Broucke (S)

Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.

Blaise Genton (B)

Swiss Tropical and Public Health Institute, Basel, Switzerland.
Center for Primary Care and Public Health, University of Lausanne, Switzerland.

Emmanuel Bottieau (E)

Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.

Valérie d'Acremont (V)

Swiss Tropical and Public Health Institute, Basel, Switzerland.
Center for Primary Care and Public Health, University of Lausanne, Switzerland.

Natalia Rodriguez-Valero (N)

ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.

Alex Almuedo-Riera (A)

ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.

Leire Balerdi-Sarasola (L)

ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.

Carme Subirà (C)

ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.

Marc Fernandez-Pardos (M)

ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.

Miguel J Martinez (MJ)

Microbiology Department, Hospital Clínic Barcelona, Spain.

Jessica Navero-Castillejos (J)

Microbiology Department, Hospital Clínic Barcelona, Spain.

Isabel Vera (I)

ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.

Jara Llenas-Garcia (J)

Internal Medicine - Infectious Diseases, Vega Baja Hospital, Orihuela, Alicante, Spain.
Clinical Medicine Department, University Miguel Hernández, Elche, Alicante, Spain.

Camilla Rothe (C)

Division of Infectious Diseases and Tropical Medicine, University Hospital LMU, Munich, Germany.

Dániel Cadar (D)

Bernhard Nocht Institute for Tropical Medicine, National Reference Centre for Tropical Pathogens, Hamburg, Germany.

Marjan Van Esbroeck (M)

Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.

Nikki Foque (N)

Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.

Jose Muñoz (J)

ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH